Central sleep apnea (CSA) is fundamentally different from obstructive sleep apnea (OSA). The former is characterized by ...
Automatic transvenous phrenic nerve stimulation demonstrates high nightly use and therapy adherence in adults with central ...
HOUSTON -- Use of transvenous phrenic nerve stimulation (TPNS) was linked to a five-fold higher chance of better clinical outcomes for patients with central sleep apnea and heart failure, according to ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images Sleep ...
Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...
Though the American Medical Association reports that about 30 million people in the US live with sleep apnea, only one-fifth ...
The MarketWatch News Department was not involved in the creation of this content. ATLANTA, Dec. 17, 2025 /PRNewswire/ -- Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA ...
February was heart month, and this is another column in a series about the primary risk factors for heart disease. Sleep apnea refers to periodic absence of breathing during sleep. There are two types ...
A task force of experts commissioned by the American Academy of Sleep Medicine (AASM) have released updated recommendations for the treatment of central sleep apnea, published in the Journal of ...
The Hearty Soul on MSN
Sleep apnea sufferers might be able to say goodbye to CPAP machines for good
An estimated 1 billion people between the ages of 30 and 69 across the globe suffer from sleep apnea, particularly obstructive sleep apnea, according to a 2019 study. To treat sleep apnea, healthcare ...
LOS ANGELES — Individuals with both uncontrolled epilepsy and sleep apnea are at significantly higher risk for mortality than those with epilepsy alone, according to a new analysis of over 2 million ...
The FDA clearance follows the presentation of SANSA clinical performance data earlier this year at the SLEEP meeting. The study, drawing on data collected from 325 patients across 7 clinical sites, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results